Vitasora Health (ASX:VHL) has completed its $11 million capital raise, following the full receipt of a $6.8 million cornerstone investment at a placement price of $0.03 per share.
This follows the earlier $3.7 million strategic placement to new and existing investors during the September 2025 quarter, with an additional commitment of $100,000 from Nicholas Smedley and Marjan Mikel pending shareholder approval.
The completion of the capital raise strengthens Vitasora's balance sheet, providing a solid funding base to support its US growth strategy and advance operations across Medicaid and fee-for-service programs.
Operational highlights for the September quarter included a 7.6% increase in active patient programs to 22,458, the onboarding of approximately 1,000 patients through its partnership with Iris Medical Group, and expansion of Tampa Family Health Centers and Family Care (West Virginia) programs.
With a strengthened capital position, Vitasora is well positioned to continue scaling its Connected Care services, maintain investment in automation and AI-enabled initiatives, and achieve cash flow breakeven by the end of FY26.
At the time of reporting, Vitasora Health's share price was $0.024.